These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32174919)

  • 1. Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology.
    Kaufmann SHE
    Front Immunol; 2020; 11():316. PubMed ID: 32174919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis vaccines: beyond bacille Calmette-Guerin.
    McShane H
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2782-9. PubMed ID: 21893541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.
    Kaufmann SH; Baumann S; Nasser Eddine A
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1068-79. PubMed ID: 17044198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant live vaccine candidates against tuberculosis.
    Kaufmann SH; Gengenbacher M
    Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.
    Woodworth JS; Clemmensen HS; Battey H; Dijkman K; Lindenstrøm T; Laureano RS; Taplitz R; Morgan J; Aagaard C; Rosenkrands I; Lindestam Arlehamn CS; Andersen P; Mortensen R
    Nat Commun; 2021 Nov; 12(1):6658. PubMed ID: 34795205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
    Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
    Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
    Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M; Soleimanpour S
    Expert Rev Vaccines; 2018 Jan; 17(1):31-44. PubMed ID: 29148853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F
    Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future vaccination strategies against tuberculosis: thinking outside the box.
    Kaufmann SH
    Immunity; 2010 Oct; 33(4):567-77. PubMed ID: 21029966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination Strategies Against Mycobacterium tuberculosis: BCG and Beyond.
    Ferluga J; Yasmin H; Bhakta S; Kishore U
    Adv Exp Med Biol; 2021; 1313():217-240. PubMed ID: 34661897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in tuberculosis vaccines.
    Haile M; Källenius G
    Curr Opin Infect Dis; 2005 Jun; 18(3):211-5. PubMed ID: 15864097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.